INTUITIVE SURGICAL $ISRG Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $3.05B (Est. $2.91B) 🟢; +22% YoY 🔹 Adj. EPS: $3.00 (Est. $2.64) 🟢; +25% YoY 🔹 GAAP EPS: $1.49; -24% YoY 🔹 Adj. Gross Margin: 69.9% FY26 Guide: 🔹 da Vinci Procedure Growth: ~+14%-+15% 🔹 Adj. Gross Margin: 68.7%-69.3% 🔹 Adj. Opex Growth: +11%-+13% Revenue Breakdown: 🔹 Instruments & Accessories: $1.80B; +18% YoY 🔹 Systems: $769M; +30% YoY 🔹 Services: $482.2M Procedures: 🔹 Worldwide: ~+15% YoY 🔹 da Vinci: ~+14% YoY 🔹 Ion: ~+31% YoY System Placements: 🔹 da Vinci: 546; +28% YoY 🔹 da Vinci 5: 315; +31% YoY 🔹 Ion: 56; +12% YoY Other Q3 Metrics: 🔹 da Vinci Installed Base: 12,094; +12% YoY 🔹 Ion Installed Base: 1,152; +21% YoY 🔹 Adj. Oper Income: $1.27B (Est. $1.13B) 🟢 Key Updates: 🔹 Antitrust settlement charge: $450M; $347M net of tax, $0.99/share 🔹 IEEPA tariff refund benefit: $22M net of tax, $0.06/share; in GAAP and non-GAAP 🔹 Expects da Vinci procedure growth closer to the midpoint of the range 🔹 Share Repurchases: $2.94B; 7.8M shares 🔹 Cash, cash equivalents, and investments: $6.80B Comments: 🔸 “Our strong performance this quarter was marked by broad-based adoption across our multi-port, single-port, and Ion platforms, with customers using our systems to perform, on average, over 10,000 procedures per day throughout the period.”